• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT ANTI-HBS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT ANTI-HBS Back to Search Results
Catalog Number 07C18-29
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/27/2020
Event Type  malfunction  
Manufacturer Narrative
Patient identifier: complete entry = (b)(6).Patient information: no further information was provided.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer obtained a (b)(6) architect (b)(6) result for a (b)(6) female patient.Sample id (b)(6) generated 13.31 miu/ml for (b)(6) and also generated a (b)(6) result (126.62 iu/ml) for (b)(6).The patient has a history of being (b)(6) for both (b)(6) (67.54 to >250 iu/ml) and (b)(6) (12.14 to 18.5 miu/ml).No impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation included a search for similar complaints, and review of complaint text, trending data, labelling, and device history records.Return testing was not completed as returns were not available.A review of complaint activity determined that there was normal complaint activity for reagent lot 06340fn00.The overall performance of reagent lot 06340fn00 was evaluated using worldwide field data and indicated that the performance of the lot is acceptable.Review of tracking and trending reports did not identify any related trends for the architect anti-hbs assay.Device history record review on lot 06340fn00 did not identify any issues.Labeling was reviewed and found to adequately address the issue under review.Based on the investigation, no systemic issue or deficiency of the architect anti-hbs assay, lot number 06340fn00 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT ANTI-HBS
Type of Device
ANTI-HBS
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
diagnostics division
sligo NA
EI  NA
MDR Report Key10148003
MDR Text Key199450505
Report Number3008344661-2020-00044
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 07/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/27/2020
Device Catalogue Number07C18-29
Device Lot Number06340FN00
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/27/2020
Initial Date FDA Received06/12/2020
Supplement Dates Manufacturer Received07/01/2020
Supplement Dates FDA Received07/08/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR, LIST 03M74-01,; ARCHITECT I2000SR, LIST 03M74-01,; SERIAL (B)(6) ; SERIAL (B)(6)
Patient Age67 YR
-
-